Optibrium, a leading developer of software and AI solutions for molecular design, today announced a new QuanSA™ plugin for ...

A new plugin enables chemists to predict drug binding affinity using a visual interface, combining machine learning, and molecular modeling to improve lead optimization, and reduce experimental ...

The team, from biopharmaceutical company Regeneron, hopes their work will help researchers better understand protein-protein interactions during preclinical development of a drug. “Essentially, we ...